Concert Pharmaceuticals Earning Date (CNCE)

USA |NASDAQ |USD

CNCE Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Feb 23, 2022 Dec 2021 $-0.73 $-0.78 $-0.69
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Feb 23, 2022 Dec 2021 $20.00K $543.00K $7.00K

Concert Pharmaceuticals's next earnings date is Wednesday, Feb 23, 2022 for the fiscal quarter ending Dec 2021.

CNCE Earnings Date & History Chart

CNCE Earnings & Revenue Forecast

CNCE Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.73 $-0.93 $-0.56
Mar 2022 2 $-0.79 $-1.00 $-0.58
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-2.05 $-2.23 $-1.89
Dec 2022 6 $-2.91 $-3.49 $-1.96

CNCE Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 2 / 1 $-0.80 $-0.80 $-0.80
Mar 2022 0 / 0 $-1.00 $-1.00 $-1.00
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 3 / 0 $-2.14 $-2.14 $-2.14
Dec 2022 1 / 0 $-3.08 $-3.08 $-3.08

CNCE Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 3 $20.00K $0.00 $50.00K
Mar 2022 1 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $32.67M $32.56M $33.00M
Dec 2022 5 $4.51M $0.00 $20.00M

CNCE Earnings Date & Revenue History

CNCE Earnings History

|
Show More
Show More

CNCE Revenue History

|
Show More
Show More

Concert Pharmaceuticals Next Earnings Date & Report

CNCE Next Earnings Date & Report Preview: Dec 2021 (FQ)

CNCE's next earnings date is Wednesday, Feb 23, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 4 analysts, the average EPS estimation for Concert Pharmaceuticals's next quarterly earnings is $-0.73, with a low EPS estimation of $-0.93, and a high estimation of $-0.56.

Over the last 1 month, EPS estimates have seen 2 upward revisions and 1 downward. The EPS 1 month trend is $-0.80, the last 2 month trend is $-0.80, and the 3 month trend is $-0.80.

Based on 4 analysts, the average revenue estimation is $20.00K, with a low revenue estimation of $0.00, and a high estimation of $50.00K.

Concert Pharmaceuticals Previous Earnings Dates & Reports

CNCE Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Concert Pharmaceuticals's previous earnings date was Nov 9, 2021 for its fiscal quarter ended Sep 30, 2021.

CNCE's earnings per share (EPS) was $-0.78, beating the consensus analysts forecast of $-0.81 by 3.70%.

The EPS was lower than the previous fiscal quarter (Jun 2021) by -587.50%, and lower than the same period a year before (Sep 2020) by 30.00%.

Revenues were $543.00K, better than the forecast of $60.00K by 805.00%, down by -98.30% from the previous quarter , and down by -63.82% from the same period last year.

The company reported a net income of $-26.68M.

Free cash flow for the quarter was $-39.54M , compared to $10.63M last quarter and $-20.34M a year before.

CNCE ended the quarter with $1.10M in total debt, a decrease of -92.95% compared to the previous quarter, and a decrease of -93.23% compared to the same quarter a year before.

CNCE Previous Earnings Date & Report Recap: Dec 2020 (FY)

Concert Pharmaceuticals's previous annual earnings date was Feb 25, 2021 for its fiscal year ended Dec 31, 2020.

CNCE's earnings per share (EPS) was $-2.40, beating the consensus analysts forecast of $-2.53 by -5.14% , and higher than the previous year's EPS (Dec 2019) by -27.05%.

Revenues were $7.90M, worse than the forecast of $7.92M by -0.23%, and up by 633.70% from previous year's revenue.

The company reported a net income of $-74.77M.

Concert Pharmaceuticals reported a free cash flow of $-69.25M for its fiscal year, compared to $-49.45M a year ago.

The company ended the fiscal year with $16.00M in total debt, a decrease of -1.65% compared to the previous year.